Merck KGaA received a reaffirmed neutral rating, reduced its stake by 18.5%, and filed 13F reports with the SEC.
1 report, 1 independent
Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Merck KGaA received a reaffirmed neutral rating, reduced its stake by 18.5%, and filed 13F reports with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Merck KGaA
German multinational science and technology company
-
Cantor Fitzgerald
American financial services company
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Tenable Holdings, Inc. received a positive rating and a $44.00 price target from financial firms, alongside a stock sale disclosure to the SEC.
- MarketBeat provided consensus ratings while Cantor Fitzgerald and Jefferies Financial Group issued rating updates for Primoris Services Corporation.
- A company disclosed a stake purchase to the Securities and Exchange Commission on November 1, 2026.
- Cantor Fitzgerald and Jefferies Financial Group downgraded EyePoint Pharmaceuticals' stock rating from overweight/buy to neutral/hold on October 19, 2026.
- Disclosure made to the Securities and Exchange Commission involving Northern Trust on July 2, 2026.
Coverage
Newest first; wire copies grouped- tickerreport.comHilltop Holdings Inc. Trims Stock Holdings in Merck & Co., Inc. $MRK